Montreal’s Noveko International Inc, which is commercializing antimicrobial filter technology across the world, has until October 23, 2009 to file extra data on its surgical masks with the US regulators. Noveko’s chief operating officer, Alain Bolduc, believes that the company’s proprietary product will be the first one among the antibacterial surgical mask products to receive the FDA approval.